Cannabinoids, Sleep, and the MCH System

  • Eric Murillo-Rodríguez
  • Daniela Morales-Lara
  • José Carlos Pastrana-Trejo
  • Lorena Macías-Triana
  • Karen Romero-Cordero
  • Miriel de-la-Cruz
  • Clelia De-la-Peña
Chapter

Abstract

Marijuana is a colloquial name given to Cannabis sativa, which has been used for diverse purposes, including as a therapeutical element for multiple health issues. The neurobiological effects of C. sativa involve a complex biological machinery including receptors, named CB1 and CB2 cannabinoid receptors. These receptors recognize endogenous cannabinoid-like compounds, such as anandamide and 2-arachinonolglycerol which seems to display sleep-inducing properties. Along decades, the study of the putative role of exogenous and endogenous cannabinoids in sleep modulation has brought critical data. Since endocannabinoids have been described in sleep-related brain areas, intriguing issues regarding whether hypothalamic substrates, such as MHC, may be interacting with the endocannabinoids have been raised.

Keywords

Cannabis sativa Cannabidiol Rapid eye movement sleep Melanin-concentrating hormone Hypothalamus 

References

  1. Abood ME (2005)Molecular biology of cannabinoid receptors. Handb Exp Pharmacol (168):81–115
  2. Al Massadi O, López M, Tschöp M, Diéguez C, Nogueiras R. Current understanding of the hypothalamic ghrelin pathways inducing appetite and adiposity. Trends Neurosci. 2017. pii: S0166–2236(16)30190–4. doi:  https://doi.org/10.1016/j.tins.2016.12.003 CrossRefPubMedGoogle Scholar
  3. Apergis-Schoute J, Iordanidou P, Faure C, Jego S, Schöne C, Aitta-Aho T, Adamantidis A, Burdakov D (2015) Optogenetic evidence for inhibitory signaling from orexin to MCH neurons via local microcircuits. J Neurosci 35(14):5435–5441.  https://doi.org/10.1523/JNEUROSCI.5269-14.2015 CrossRefPubMedPubMedCentralGoogle Scholar
  4. Basavarajappa BS, Nixon RA, Arancio O (2009) Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration. Mini Rev Med Chem 9(4):448–462CrossRefGoogle Scholar
  5. Bedse G, Romano A, Lavecchia AM, Cassano T, Gaetani S (2015) The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer’s disease. J Alzheimers Dis 43(4):1115–1136.  https://doi.org/10.3233/JAD-141635 CrossRefPubMedGoogle Scholar
  6. Bermudez-Silva FJ, Viveros MP, McPartland JM, Rodriguez de Fonseca F (2010) The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning? Pharmacol Biochem Behav 95(4):375–382.  https://doi.org/10.1016/j.pbb.2010.03.012 CrossRefPubMedGoogle Scholar
  7. Blais A, Drouin G, Chaumontet C, Voisin T, Couvelard A, Even PC, Couvineau A (2017) Impact of Orexin-A treatment on food intake, energy metabolism and body weight in mice. PLoS One 12(1):e0169908.  https://doi.org/10.1371/journal.pone.0169908 CrossRefPubMedPubMedCentralGoogle Scholar
  8. Blanco-Centurion C, Liu M, Konadhode RP, Zhang X, Pelluru D, van den Pol AN, Shiromani PJ (2016) Optogenetic activation of melanin-concentrating hormone neurons increases non-rapid eye movement and rapid eye movement sleep during the night in rats. Eur J Neurosci 44(10):2846–2857.  https://doi.org/10.1111/ejn.13410 CrossRefPubMedPubMedCentralGoogle Scholar
  9. Buonamici M, Young GA, Khazan N (1982) Effects of acute delta 9-THC administration on EEG and EEG power spectra in the rat. Neuropharmacology 21(8):825–829CrossRefGoogle Scholar
  10. Carlini EA, Cunha JM (1981) Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol. 21(8–9 Suppl):417S–427SCrossRefGoogle Scholar
  11. Carlini BH, Garrett SB, Carter GT (2017) Medicinal cannabis. Am J Hosp Palliat Care 34(1):85–91.  https://doi.org/10.1177/1049909115604669 CrossRefPubMedGoogle Scholar
  12. Cascio MG, Marini P (2015) Biosynthesis and fate of endocannabinoids. Handb Exp Pharmacol 231:39–58.  https://doi.org/10.1007/978-3-319-20825-1_2 CrossRefPubMedGoogle Scholar
  13. Chometton S, Croizier S, Fellmann D, Risold PY (2016) The MCH neuron population as a model for the development and evolution of the lateral and dorsal hypothalamus. J Chem Neuroanat 75(Pt A):28–31.  https://doi.org/10.1016/j.jchemneu.2015.09.004 CrossRefPubMedGoogle Scholar
  14. Chowen JA, Argente-Arizón P, Freire-Regatillo A, Frago LM, Horvath TL, Argente J (2016) The role of astrocytes in the hypothalamic response and adaptation to metabolic signals. Prog Neurobiol 144:68–87.  https://doi.org/10.1016/j.pneurobio.2016.03.001 CrossRefPubMedGoogle Scholar
  15. de Lecea L (2015) Optogenetic control of hypocretin (orexin) neurons and arousal circuits. Curr Top Behav Neurosci 25:367–378.  https://doi.org/10.1007/7854_2014_364 CrossRefPubMedPubMedCentralGoogle Scholar
  16. Devera A, Pascovich C, Lagos P, Falconi A, Sampogna S, Chase MH, Torterolo P (2015) Melanin-concentrating hormone (MCH) modulates the activity of dorsal raphe neurons. Brain Res 1598:114–128.  https://doi.org/10.1016/j.brainres.2014.12.032 CrossRefPubMedPubMedCentralGoogle Scholar
  17. Di Cristoforo A, Cerri M, Del Vecchio F, Hitrec T, Luppi M, Perez E, Zamboni G, Amici R (2015) Wake-sleep, thermoregulatory, and autonomic effects of cholinergic activation of the lateral hypothalamus in the rat: a pilot study. Arch Ital Biol 153(2–3):67–76.  https://doi.org/10.12871/000398292015232 CrossRefPubMedGoogle Scholar
  18. Dias Abdo Agamme AL, Aguilar Calegare BF, Fernandes L, Costa A, Lagos P, Torterolo P, D'Almeida V (2015) MCH levels in the CSF, brain preproMCH and MCHR1 gene expression during paradoxical sleep deprivation, sleep rebound and chronic sleep restriction. Peptides 74:9–15.  https://doi.org/10.1016/j.peptides.2015.10.001 CrossRefPubMedPubMedCentralGoogle Scholar
  19. Egertová M, Simon GM, Cravatt BF, Elphick MR (2008) Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: a new perspective on N-acylethanolamines as neural signaling molecules. J Comp Neurol 506(4):604–615CrossRefGoogle Scholar
  20. Elphick MR, Egertová M (2001) The neurobiology and evolution of cannabinoid signalling. Philos Trans R Soc Lond Ser B Biol Sci 356(1407):381–408CrossRefGoogle Scholar
  21. ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A (2017) Phytochemistry of Cannabis sativa L. Prog Chem Org Nat Prod 103:1–36.  https://doi.org/10.1007/978-3-319-45541-9_1 CrossRefPubMedGoogle Scholar
  22. Fakhoury M (2017) Role of the endocannabinoid system in the pathophysiology of schizophrenia. Mol Neurobiol 54(1):768–778.  https://doi.org/10.1007/s12035-016-9697-5 CrossRefPubMedGoogle Scholar
  23. Feinberg I, Jones R, Walker JM, Cavness C, March J (1975) Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man. Clin Pharmacol Ther 17(4):458–466CrossRefGoogle Scholar
  24. Feinberg I, Jones R, Walker J, Cavness C, Floyd T (1976) Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns. Clin Pharmacol Ther 19(6):782–794CrossRefGoogle Scholar
  25. Fernández-Ruiz J, Romero J, Ramos JA (2015) Endocannabinoids and neurodegenerative disorders: Parkinson’s disease, Huntington’s chorea, Alzheimer’s disease, and others. Handb Exp Pharmacol 231:233–259.  https://doi.org/10.1007/978-3-319-20825-1_8 CrossRefPubMedGoogle Scholar
  26. Fraigne JJ, Grace KP, Horner RL, Peever J (2014) Mechanisms of REM sleep in health and disease. Curr Opin Pulm Med 20(6):527–532.  https://doi.org/10.1097/MCP.0000000000000103 CrossRefPubMedGoogle Scholar
  27. Freemon FR (1972) Effects of marijuana on sleeping states. JAMA 220(10):1364–1365CrossRefGoogle Scholar
  28. Gao Y, Sun T (2016) Molecular regulation of hypothalamic development and physiological functions. Mol Neurobiol 53(7):4275–4285.  https://doi.org/10.1007/s12035-015-9367-z CrossRefPubMedGoogle Scholar
  29. Gatta-Cherifi B, Cota D (2015) Endocannabinoids and metabolic disorders. Handb Exp Pharmacol 231:367–391.  https://doi.org/10.1007/978-3-319-20825-1_13 CrossRefPubMedGoogle Scholar
  30. Gerra G, Zaimovic A, Gerra ML, Ciccocioppo R, Cippitelli A, Serpelloni G, Somaini L (2010) Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists. Recent Pat CNS Drug Discov 5(1):46–52CrossRefGoogle Scholar
  31. Gertsch J, Pertwee RG, Di Marzo V (2010) Phytocannabinoids beyond the cannabis plant—do they exist? Br J Pharmacol 160(3):523–529.  https://doi.org/10.1111/j.1476-5381.2010.00745.x CrossRefPubMedPubMedCentralGoogle Scholar
  32. Gilbert MT, Soderstrom K (2013) Novel song-stimulated dendritic spine formation and Arc/Arg3.1 expression in zebra finch auditory telencephalon are disrupted by cannabinoid agonism. Brain Res 1541:9–21.  https://doi.org/10.1016/j.brainres.2013.10.012 CrossRefPubMedPubMedCentralGoogle Scholar
  33. González JA, Iordanidou P, Strom M, Adamantidis A, Burdakov D (2016) Awake dynamics and brain-wide direct inputs of hypothalamic MCH and orexin networks. Nat Commun 7:11395.  https://doi.org/10.1038/ncomms11395 CrossRefPubMedPubMedCentralGoogle Scholar
  34. Gruden G, Barutta F, Kunos G, Pacher P (2016) Role of the endocannabinoid system in diabetes and diabetic complications. Br J Pharmacol 173(7):1116–1127.  https://doi.org/10.1111/bph.13226 CrossRefPubMedGoogle Scholar
  35. Guindon J, Hohmann AG (2011) The endocannabinoid system and cancer: therapeutic implication. Br J Pharmacol 163(7):1447–1463.  https://doi.org/10.1111/j.1476-5381.2011.01327.x CrossRefPubMedPubMedCentralGoogle Scholar
  36. Haney M, Gunderson EW, Rabkin J, Hart CL, Vosburg SK, Comer SD, Foltin RW (2007) Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. J Acquir Immune Defic Syndr 45(5):545–554CrossRefGoogle Scholar
  37. Hsiao YT, Yi PL, Li CL, Chang FC (2012) Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats. Neuropharmacology 62(1):373–384.  https://doi.org/10.1016/j.neuropharm.2011.08.013 CrossRefPubMedGoogle Scholar
  38. Huang H, Acuna-Goycolea C, Li Y, Cheng HM, Obrietan K, van den Pol AN (2007) Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexinneurons: implications for cannabinoid actions on food intake and cognitive arousal. J Neurosci 27(18):4870–4881CrossRefGoogle Scholar
  39. Iversen L (2003) Cannabis and the brain. Brain 126(Pt 6):1252–1270CrossRefGoogle Scholar
  40. Jourdan T, Godlewski G, Kunos G (2016) Endocannabinoid regulation of β-cell functions: implications for glycemic control and diabetes. Diabetes Obes Metab 18(6):549–557.  https://doi.org/10.1111/dom.12646 CrossRefPubMedPubMedCentralGoogle Scholar
  41. Katona I (2015) Cannabis and endocannabinoid signaling in epilepsy. Handb Exp Pharmacol 231:285–316.  https://doi.org/10.1007/978-3-319-20825-1_10 CrossRefPubMedGoogle Scholar
  42. Konadhode RR, Pelluru D, Shiromani PJ (2015) Neurons containing orexin or melanin concentrating hormone reciprocally regulate wake and sleep. Front Syst Neurosci 8:244.  https://doi.org/10.3389/fnsys.2014.00244. ReviewCrossRefPubMedPubMedCentralGoogle Scholar
  43. Krug RG 2nd, Clark KJ (2015) Elucidating cannabinoid biology in zebrafish (Danio rerio). Gene 570(2):168–179.  https://doi.org/10.1016/j.gene.2015.07.036 CrossRefPubMedPubMedCentralGoogle Scholar
  44. Laprairie RB, Bagher AM, Denovan-Wright EM (2016) Cannabinoid receptor ligand bias: implications in the central nervous system. Curr Opin Pharmacol 32:32–43.  https://doi.org/10.1016/j.coph.2016.10.005 CrossRefPubMedGoogle Scholar
  45. Li SB, Giardino WJ, de Lecea L (2016) Hypocretins and arousal. Curr Top Behav Neurosci.  https://doi.org/10.1007/7854_2016_58
  46. McPartland JM, Agraval J, Gleeson D, Heasman K, Glass M (2006) Cannabinoid receptors in invertebrates. J Evol Biol 19(2):366–373CrossRefGoogle Scholar
  47. Mechoulam R, Parker LA (2013) The endocannabinoid system and the brain. Annu Rev Psychol 64:21–47.  https://doi.org/10.1146/annurev-psych-113011-143739 CrossRefPubMedGoogle Scholar
  48. Mehta R, Khanday MA, Mallick BN (2015) REM sleep loss associated changes in orexin-A levels in discrete brain areas in rats. Neurosci Lett 590:62–67.  https://doi.org/10.1016/j.neulet.2015.01.067 CrossRefPubMedGoogle Scholar
  49. Mijangos-Moreno S, Poot-Aké A, Arankowsky-Sandoval G, Murillo-Rodríguez E (2014) Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats. Neurosci Res 84:60–63CrossRefGoogle Scholar
  50. Monti JM (1977) Hypnoticlike effects of cannabidiol in the rat. Psychopharmacology 55(3):263–265CrossRefGoogle Scholar
  51. More SV, Choi DK (2015) Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection. Mol Neurodegener 10:17.  https://doi.org/10.1186/s13024-015-0012-0 CrossRefPubMedPubMedCentralGoogle Scholar
  52. Morena M, Patel S, Bains JS, Hill MN (2016) Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology 41(1):80–102.  https://doi.org/10.1038/npp.2015.166 CrossRefPubMedGoogle Scholar
  53. Murillo-Rodríguez E, Millán-Aldaco D, Palomero-Rivero M, Mechoulam R, Drucker-Colín R (2006a) Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats. FEBS Lett 580:4337–4345CrossRefGoogle Scholar
  54. Murillo-Rodríguez E, Desarnaud F, Prospéro-Garcia O (2006b) Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat. Life Sci 79:30–37CrossRefGoogle Scholar
  55. Murillo-Rodríguez E, Millán-Aldaco D, Palomero-Rivero M, Mechoulam R, Drucker-Colín R (2008) The non-psychoactive cannabis constituent cannabidiol is a wake-inducing agent. Behav Neurosci 122:1378–1382CrossRefGoogle Scholar
  56. Murillo-Rodríguez E, Poot-Ake A, Arias-Carrion O, Pacheco-Pantoja E, Fuente-Ortegon Ade L, Arankowsky-Sandoval G (2011a) The emerging role of the endocannabinoid system in the sleep-wake cycle modulation. Cent Nerv Syst Agents Med Chem 11(3):189–196CrossRefGoogle Scholar
  57. Murillo-Rodríguez E, Palomero-Rivero M, Millán-Aldaco D, Mechoulam R, Drucker-Colín R (2011b) Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats. Life Sci 88:504–511CrossRefGoogle Scholar
  58. Nicholson AN, Turner C, Stone BM, Robson PJ (2004) Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 24(3):305–313CrossRefGoogle Scholar
  59. Pérez-Morales M, De La Herrán-Arita AK, Méndez-Díaz M, Ruiz-Contreras AE, Drucker-Colín R, Prospéro-García O (2013) 2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats. Pharmacol Biochem Behav 108:1–7.  https://doi.org/10.1016/j.pbb.2013.04.006 CrossRefPubMedGoogle Scholar
  60. Pertwee RG (2015) Endocannabinoids and their pharmacological actions. Handb Exp Pharmacol 231:1–37.  https://doi.org/10.1007/978-3-319-20825-1_1 CrossRefPubMedGoogle Scholar
  61. Pivik RT, Zarcone V, Dement WC, Hollister LE (1972) Delta-9-tetrahydrocannabinol and synhexl: effects on human sleep patterns. Clin Pharmacol Ther 13(3):426–435CrossRefGoogle Scholar
  62. Rubino T, Zamberletti E, Parolaro D (2015) Endocannabinoids and mental disorders. Handb Exp Pharmacol 231:261–283.  https://doi.org/10.1007/978-3-319-20825-1_9 CrossRefPubMedGoogle Scholar
  63. Schafroth MA, Carreira EM (2017) Synthesis of phytocannabinoids. Prog Chem Org Nat Prod 103:37–59.  https://doi.org/10.1007/978-3-319-45541-9_2 CrossRefPubMedGoogle Scholar
  64. Schierenbeck T, Riemann D, Berger M, Hornyak M (2008) Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. Sleep Med Rev 12(5):381–389.  https://doi.org/10.1016/j.smrv.2007.12.004 CrossRefPubMedGoogle Scholar
  65. Schwartz MD, Kilduff TS (2015) The neurobiology of sleep and wakefulness. Psychiatr Clin North Am 38(4):615–644.  https://doi.org/10.1016/j.psc.2015.07.002 CrossRefPubMedPubMedCentralGoogle Scholar
  66. Sido JM, Nagarkatti PS, Nagarkatti M (2015) Role of endocannabinoid activation of peripheral CB1 receptors in the regulation of autoimmune disease. Int Rev Immunol 34(5):403–414.  https://doi.org/10.3109/08830185.2014.921165 CrossRefPubMedGoogle Scholar
  67. Torterolo P, Scorza C, Lagos P, Urbanavicius J, Benedetto L, Pascovich C, López-Hill X, Chase MH, Monti JM (2015) Melanin-concentrating hormone (MCH): role in rem sleep and depression. Front Neurosci 9:475.  https://doi.org/10.3389/fnins.2015.00475 CrossRefPubMedPubMedCentralGoogle Scholar
  68. Urbanavicius J, Lagos P, Torterolo P, Abin-Carriquiry JA, Scorza C (2016) Melanin-concentrating hormone projections to the dorsal raphe nucleus: an immunofluorescence and in vivo microdialysis study. J Chem Neuroanat 72:16–24.  https://doi.org/10.1016/j.jchemneu.2015.11.010 CrossRefPubMedPubMedCentralGoogle Scholar
  69. Valenti M, Viganò D, Casico MG, Rubino T, Steardo L, Parolaro D, Di Marzo V (2004) Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. Cell Mol Life Sci 61(7–8):945–950CrossRefGoogle Scholar
  70. Vetrivelan R, Kong D, Ferrari LL, Arrigoni E, Madara JC, Bandaru SS, Lowell BB, Lu J, Saper CB (2016) Melanin-concentrating hormone neurons specifically promote rapid eye movement sleep in mice. Neuroscience 336:102–113.  https://doi.org/10.1016/j.neuroscience.2016.08.046 CrossRefPubMedPubMedCentralGoogle Scholar
  71. Walsh Z, Gonzalez R, Crosby K, S Thiessen M, Carroll C, Bonn-Miller MO (2017) Medical cannabis and mental health: a guided systematic review. Clin Psychol Rev 51:15–29.  https://doi.org/10.1016/j.cpr.2016.10.002 CrossRefPubMedGoogle Scholar
  72. Woodhams SG, Sagar DR, Burston JJ, Chapman V (2015) The role of the endocannabinoid system in pain. Handb Exp Pharmacol 227:119–143.  https://doi.org/10.1007/978-3-662-46450-2_7 CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Eric Murillo-Rodríguez
    • 1
    • 2
    • 3
  • Daniela Morales-Lara
    • 1
    • 2
    • 3
  • José Carlos Pastrana-Trejo
    • 1
    • 2
    • 3
  • Lorena Macías-Triana
    • 1
    • 2
    • 3
  • Karen Romero-Cordero
    • 1
    • 2
    • 3
  • Miriel de-la-Cruz
    • 1
    • 2
    • 3
  • Clelia De-la-Peña
    • 4
  1. 1.Laboratorio de Neurociencias Moleculares e Integrativas, Escuela de Medicina, División Ciencias de la SaludUniversidad Anáhuac MayabMéridaMexico
  2. 2.Grupo de Investigación en Envejecimiento, División Ciencias de la SaludUniversidad Anáhuac MayabMéridaMexico
  3. 3.Intercontinental Neuroscience Research GroupMéridaMexico
  4. 4.Centro de Investigación Científica de Yucatán. A.CUnidad de BiotecnologíaMéridaMexico

Personalised recommendations